A Long-term Administration study of SEP-363856 in people with Schizophrenia
This study is recruiting. It focuses on schizophrenia and currently lists participation information in Japan.
In Fukuoka
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is recruiting. It focuses on schizophrenia and currently lists participation information in Japan.
In FukuokaThis study is recruiting in the United States. It is testing ML-007C-MA for schizophrenia.
Multiple locations, including Lemon GroveThis study is recruiting. It focuses on depression and currently lists participation information in the United States.
In The BronxThis study is recruiting in the United Kingdom. It is testing ethyl-eicosapentaenoate (ethyl-EPA) for schizophrenia.
In United KingdomThis study is recruiting. It focuses on schizophrenia and currently lists participation information in the United Kingdom.
In United KingdomThis study is recruiting. It focuses on depression and currently lists participation information in Canada.
In New WestminsterThis study is recruiting. It focuses on bipolarity and currently lists participation information in the United States.
In San DiegoThis study is recruiting. It focuses on schizophrenia and currently lists participation information in the United Kingdom.
In United KingdomThis study is recruiting in China. It focuses on Schizophrenia.
In BeijingThis study is recruiting in the United Kingdom. It focuses on Schizophrenia.
In United KingdomThis study is recruiting in South Korea. It focuses on Schizophrenia.
In SeoulThis study is recruiting in the United Kingdom, in Bulgaria, in Colombia, .... It focuses on schizophrenia.
In United Kingdom